Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Prev Med. 2022 Jul 8;162:107157. doi: 10.1016/j.ypmed.2022.107157

Table 1.

Characteristics of study populations of women living with human immunodeficiency virus (HIV) (WLWH) matched with those who were not (HIV[−] women).

HIV[−] Women (n=67,488) WLWH (n=608)
n % n % P
Race
 Missing/Unknown 18,727 27.7 58 9.5 <0.001
 White 23,489 34.8 160 26.3
 Black 3,976 6.9 248 40.8
 Asian/Pacific Islander 10,911 16.2 51 8.4
 Hispanic 9,224 13.7 73 12.1
 Native American 273 0.4 4 0.7
 Other 888 1.3 14 2.3
HPV Results
 Positive 4,355 6.5 123 20.2 <0.001
 Negative 6,1966 91.8 475 78.1
 Missing 11,167 1.7 10 1.6
Cytology Results
 Non-normal 2,615 3.9 84 13.8 <0.001
 Normal* 64,713 95.9 522 85.9
 Missing 160 0.2 2 0.3
 High-Grade** 547 0.8 9 1.5 <0.001
 Low-Grade 2,068 3.1 75 12.3
 Negative* 64,713 95.9 522 85.9
 Missing 160 0.2 2 0.3
Number of follow-up visits
 1 28,834 42.7 146 24.0 <0.001
 2 15,173 22.5 100 16.4
 3 8,972 13.2 78 12.8
 4 6,775 10.0 63 10.4
 5 4,301 6.4 70 11.5
 ≥6 3,433 5.1 151 24.8
*

Included atypical squamous cells of undetermined significance if the concurrent HPV test was negative.

**

Included cancer, high-grade squamous intraepithelial lesion (HSIL, atypical squamous cells cannot rule out HSIL, and atypical glandular cells.